Glucocerebrosidase mutations in Thai patients with Parkinson's disease

Parkinsonism and Related Disorders

Volumn 20, Issue 9, 2014, Pages 986-991

  Pulkes, Teeratorn ^a   Choubtum, Lulin ^a   Chitphuk, Sermsiri ^a   Thakkinstian, Ammarin ^a   Pongpakdee, Sunsanee ^b   Kulkantrakorn, Kongkiat ^c   Hanchaiphiboolkul, Suchat ^d   Tiamkao, Somsak ^e   Boonkongchuen, Pairoj ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b BHUMIBOL ADULYADEJ HOSPITAL   (Thailand)

^c THAMMASAT UNIVERSITY   (Thailand)

^d PRASAT NEUROLOGICAL INSTITUTE   (Thailand)

^e KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Beta glucosidase; Early onset Parkinson's disease; Familial Parkinson's disease; Glucocerebrosidase

Indexed keywords

GLUCOSYLCERAMIDASE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BODY EQUILIBRIUM; BRADYKINESIA; CHINESE; CODON; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; ETHNICITY; EXON; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; ONSET AGE; PARKINSON DISEASE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; RIGIDITY; RISK FACTOR; RNA SPLICING; SEQUENCE ANALYSIS; SMOKING; THAILANDER; TREMOR; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; MIDDLE AGED; MUTATION;

ADULT; AGE OF ONSET; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCOSYLCERAMIDASE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; RISK FACTORS;

EID: 84906318732     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.06.007     Document Type: Article

References (30)

1. Wafaei J.R., Choy F.Y. Glucocerebrosidase recombinant allele: molecular evolution of the glucocerebrosidase gene and pseudogene in primates. Blood Cells, Molecules Diseases 2005, 35:277-285.
2. Hruska K.S., LaMarca M.E., Scott C.R., Sidransky E. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat 2008, 29:567-583.
3. Suwannarat P., Keeratichamroen S., Wattanasirichaigoon D., Ngiwsara L., Cairns J.R., Svasti J., et al. Molecular characterization of type 3 (neuronopathic) Gaucher disease in Thai patients. Blood Cells, Molecules Diseases 2007, 39:348-352.
4. Lwin A., Orvisky E., Goker-Alpan O., LaMarca M.E., Sidransky E. Glucocerebrosidase mutations in subjects with parkinsonism. Mol Genet Metab 2004, 81:70-73.
5. Aharon-Peretz J., Rosenbaum H., Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. NEngl J Med 2004, 351:1972-1977.
6. Wu Y.R., Chen C.M., Chao C.Y., Ro L.S., Lyu R.K., Chang K.H., et al. Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese. JNeurol Neurosurg Psychiatr 2007, 78:977-979.
7. Ziegler S.G., Eblan M.J., Gutti U., Hruska K.S., Stubblefield B.K., Goker-Alpan O., et al. Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease. Mol Genet Metab 2007, 91:195-200.
8. Sidransky E., Nalls M.A., Aasly J.O., Aharon-Peretz J., Annesi G., Barbosa E.R., et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. NEngl J Med 2009, 361:1651-1661.
9. Mitsui J., Mizuta I., Toyoda A., Ashida R., Takahashi Y., Goto J., et al. Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol 2009, 66:571-576.
10. Neumann J., Bras J., Deas E., O'Sullivan S.S., Parkkinen L., Lachmann R.H., et al. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain 2009, 132:1783-1794.
11. Kalinderi K., Bostantjopoulou S., Paisan-Ruiz C., Katsarou Z., Hardy J., Fidani L. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece. Neurosci Lett 2009, 452:87-89.
12. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. JNeurol Neurosurg Psychiatry 1992, 55:181-184.
13. Guimaraes Bde C., Pereira A.C., Rodrigues Fda C., dos Santos A.V., Campos M., dos Santos J.M., et al. Glucocerebrosidase N370S and L444P mutations as risk factors for Parkinson's disease in Brazilian patients. Parkinsonism Relat Disord 2012, 18:688-689.
14. Tayebi N., Cushner S., Sidransky E. Differentiation of the glucocerebrosidase gene from pseudogene by long-template PCR: implications for Gaucher disease. Am J Hum Genet 1996, 59:740-741.
15. Reese M.G., Eeckman F.H., Kulp D., Haussler D. Improved splice site detection in Genie. JComputational Biology : A Journal Computational Molecular Cell Biology 1997, 4:311-323.
16. Tammachote R., Tongkobpetch S., Srichomthong C., Phipatthanananti K., Pungkanon S., Wattanasirichaigoon D., et al. Acommon and two novel GBA mutations in Thai patients with Gaucher disease. JHum Genet 2013, 58:594-599.
17. Choi J.M., Kim W.C., Lyoo C.H., Kang S.Y., Lee P.H., Baik J.S., et al. Association of mutations in the glucocerebrosidase gene with Parkinson disease in a Korean population. Neurosci Lett 2012, 514:12-15.
18. Huang C.L., Wu-Chou Y.H., Lai S.C., Chang H.C., Yeh T.H., Weng Y.H., et al. Contribution of glucocerebrosidase mutation in a large cohort of sporadic Parkinson's disease in Taiwan. Eur J Neurol 2011, 18:1227-1232.
19. Lesage S., Anheim M., Condroyer C., Pollak P., Durif F., Dupuits C., et al. Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease. Hum Mol Genet 2011, 20:202-210.
20. Jeong S.Y., Park S.J., Kim H.J. Clinical and genetic characteristics of Korean patients with Gaucher disease. Blood Cells Mol Dis 2011, 46:11-14.
21. Chahine L.M., Qiang J., Ashbridge E., Minger J., Yearout D., Horn S., et al. Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations. JAMA Neurol 2013, 70:852-858.
22. Winder-Rhodes S.E., Evans J.R., Ban M., Mason S.L., Williams-Gray C.H., Foltynie T., et al. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort. Brain 2013, 136:392-399.
23. Angeli A., Mencacci N.E., Duran R., Aviles-Olmos I., Kefalopoulou Z., Candelario J., et al. Genotype and phenotype in Parkinson's disease: lessons in heterogeneity from deep brain stimulation. Mov Disord 2013, 28:1370-1375.
24. Mao X.Y., Burgunder J.M., Zhang Z.J., An X.K., Zhang J.H., Yang Y., et al. Association between GBA L444P mutation and sporadic Parkinson's disease from Mainland China. Neurosci Lett 2010, 469:256-259.
25. Bozi M., Papadimitriou D., Antonellou R., Moraitou M., Maniati M., Vassilatis D.K., et al. Genetic assessment of familial and early-onset Parkinson's disease in a Greek population. Eu J Neurol 2014, 21(7):963-968.
26. Beutler E. Modern diagnosis and treatment of Gaucher's disease. Am J Dis Child 1993, 147:1175-1183.
27. Li Y., Sekine T., Funayama M., Li L., Yoshino H., Nishioka K., et al. Clinicogenetic study of GBA mutations in patients with familial Parkinson's disease. Neurobiol Aging 2014, 35(935):e3-e8.
28. Wang C., Cai Y., Gu Z., Ma J., Zheng Z., Tang B.S., et al. Clinical profiles of Parkinson's disease associated with common leucine-rich repeat kinase 2 and glucocerebrosidase genetic variants in Chinese individuals. Neurobiology Aging 2014, 35(725):e1-e6.
29. Anheim M., Elbaz A., Lesage S., Durr A., Condroyer C., Viallet F., et al. Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology 2012, 78:417-420.
30. Tsuang D., Leverenz J.B., Lopez O.L., Hamilton R.L., Bennett D.A., Schneider J.A., et al. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology 2012, 79:1944-1950.